Jose C. Fernandez-Checa Torres, PhD

Research Professor of Medicine (Part-Time)

Image of Jose C. Fernandez-Checa Torres, PhD
Is this your profile? Click to edit

Publications

  • Prenols and prenoic acids in metabolism, disease, and aging. J Lipid Res. 2026 Mar; 67(3):101009.. View in PubMed
  • l-Cysteine-Glutathione Mixed Disulfide, a Novel Bioavailable Sulfhydryl-Modified Glutathione Precursor, Protects against Early Liver Injury Induced by Short-Term Hypercholesterolemia. Chem Res Toxicol. 2025 11 17; 38(11):1961-1976.. View in PubMed
  • Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation. J Lipid Res. 2025 Oct; 66(10):100901.. View in PubMed
  • Bile acids in liver and gastrointestinal cancer. Semin Cancer Biol. 2025 11; 116:45-58.. View in PubMed
  • Stard1 promotes cholestatic liver injury and disease progression by sensitizing to bile acid hepatotoxicity. Hepatology. 2025 Aug 01; 82(2):293-307.. View in PubMed
  • Cholesterol’s new tricks propel MASH-HCC: impact in immunotherapy. Gut. 2024 Nov 11; 73(12):1926-1929.. View in PubMed
  • Mitochondria and Alcohol-Associated Liver Disease: Pathogenic Role and Target for Therapy. Semin Liver Dis. 2025 06; 45(2):180-194.. View in PubMed
  • Palmitoylcarnitine impairs immunity in decompensated cirrhosis. JHEP Rep. 2024 Nov; 6(11):101187.. View in PubMed
  • Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis. Mol Metab. 2024 Sep; 87:101989.. View in PubMed
  • S-Adenosyl-l-methionine restores brain mitochondrial membrane fluidity and GSH content improving Niemann-Pick type C disease. Redox Biol. 2024 06; 72:103150.. View in PubMed